Intrinsic Value of S&P & Nasdaq Contact Us

Collegium Pharmaceutical, Inc. COLL NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
66/100
4/7 Pass
SharesGrow Intrinsic Value
$57.61
+61.6%
Analyst Price Target
$58.00
+62.7%

Stock Statistics — COLL

Collegium Pharmaceutical, Inc. (COLL) has a market capitalization of $1.13B and trades at $35.64. The 52-week range is 23.23-50.787.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 18, Earnings Per Share (EPS) of $1.98, annual revenue of $780.57M.

The stock has a beta of 0.77, operates in the Healthcare sector.

Trading Data
Current Price$35.64
52-Week Range23.23-50.787
Volume503.31K
Avg Volume (30D)569.06K
Market Cap$1.13B
Beta (1Y)0.77
Company
IPO Date2015-05-07
Employees357
CEOVikram Karnani
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS19459J1043
CUSIP19459J104
Income (Latest Year)
Revenue$780.57M
Gross Profit$463.26M
EBITDA$401.01M
Operating Income$187.08M
Net Income$62.87M
EPS$1.98
EPS Diluted$1.73
Shares Outstanding$31.71M
Balance Sheet (Latest Year)
Total Assets$1.66B
Current Assets$691.41M
Cash & ST Investments$406.53M
Total Liabilities$1.36B
Total Debt$940.56M
Net Debt$689.46M
Total Equity$301.68M
Debt / Equity3.12
Valuation Ratios
P/E Ratio18
P/S Ratio1.45
P/B Ratio3.75
EV/EBITDA (approx)2.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message